By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioSystem Development has closed a financing round raising just over $1 million, the firm said after the close of the market Wednesday.

The privately-held firm said that it will use the funds to scale up its manufacturing capabilities, increase the speed to market of its new products, and support expansion of its product pipeline. The Madison, Wis.-based company makes the AssayMap platform, which enables high-throughput solutions for bioprocess development, biomarkers, and life sciences research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.